Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL566961 | 1.00 | — | — | |
| SCHEMBL21237759 | 1.00 | CA1 (0.38) | CA1CA2ACHECA12CA9 | |
| SCHEMBL40788 | 1.00 | — | — | |
| Cyclohexane SCHEMBL15212796 | 1.00 | CA1 (0.38) | CA1CA2ACHECA12CA9 | |
| SCHEMBL607695 | 1.00 | CA1 (0.38) | CA1CA2ACHECA12CA9 | |
| SCHEMBL112370 | 1.00 | CA1 (0.38) | CA1CA2ACHECA12CA9 | |
| Ammonia Solution, Strong SCHEMBL8076692 | 0.97 | CA1 (0.36) | CA1CA2ACHECA12CA9 | |
| Ammonia Solution, Strong SCHEMBL8083463 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL8078616 | 0.97 | CA1 (0.36) | CA1CA2ACHECA12CA9 | |
| Ammonia Solution, Strong SCHEMBL8069132 | 0.97 | CA1 (0.36) | CA1CA2ACHECA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| WO-2022269114-A1 | METHOD FOR PREPARING PURIFIED METHYL THUJATE, USE AS A FRAGRANCE COMPONENT AND COMPOSITION CONTAINING IT | EUROFRAGANCE, S.L.U. (ES) | 2022-12-29 | — | — | WO | disclosed |
| EP-2832441-B1 | MICROCAPSULES | TAKASAGO PERFUMERY CO LTD (JP) | 2019-09-11 | — | — | EP | disclosed |
| CN-105431225-B | Microcapsule | 高砂香料工业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| US-9895297-B2 | Microcapsules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-02-20 | — | — | US | disclosed |
| EP-3031496-B1 | RINSE-OFF COSMETIC COMPOSITIONS | TAKASAGO PERFUMERY CO LTD (JP) | 2018-01-31 | — | — | EP | disclosed |
| EP-2907568-B1 | A FRAGRANCE-DELIVERY COMPOSITION COMPRISING PERSULFATE ION-CROSSLINKED POLYVINYL ALCOHOL MICROCAPSULES AND METHOD OF USE THEREOF | ENCAPSYS LLC (US) | 2017-12-06 | — | — | EP | disclosed |
| US-20160206522-A1 | MICROCAPSULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| EP-3031496-A1 | RINSE-OFF COSMETIC COMPOSITIONS | Takasago International Corporation (JP) | 2016-06-15 | — | — | EP | disclosed |
| US-20100099594-A1 | Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof | IPS ADHESIVES LLC | 2010-04-22 | — | — | US | disclosed |
| WO-2010044834-A2 | A FRAGRANCE-DELIVERY COMPOSITION COMPRISING BORON AND PERSULFATE ION-CROSSLINKED POLYVINYL ALCOHOL MICROCAPSULES AND METHOD OF USE THEREOF | APPLETON PAPERS INC. (US) | 2010-04-22 | — | — | WO | disclosed |
| US-20100087351-A1 | Perfumes for Linear Citrus Release in Rinse-Off Systems | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2010-04-08 | — | — | US | disclosed |
| US-7538149-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20080176780-A1 | ENCAPSULATION OF BULKY FRAGRANCE MOLECULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-24 | — | — | US | disclosed |
| US-20080176781-A1 | Perfumes for linear citrus release in rinse-off systems | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2008-07-24 | — | — | US | disclosed |
| EP-1894603-A1 | Encapsulation of bulky fragrance molecules | Takasago International Corporation (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-20060258776-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2006-11-16 | — | — | US | disclosed |
| EP-1721943-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | POLRMT, DCLRE1B, RNGTT | CA1 4247/4885CA2 4580/4885ACHE 3920/4885 |
| US-20160206522-A1 | MICROCAPSULES | MITF, PLIN5, MLEC | CA1 4621/4885CA2 4535/4885ACHE 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.